Key result
In adults with chronic kidney disease, plasma prorenin and renin concentrations decreased by a mean of 2% and 5% per year, respectively, with steeper declines in those with severe CKD.
Why the study?
Prorenin and renin may have physiologic significance in CKD via renin-angiotensin regulation and angiotensin II-independent fibrosis pathways, but their plasma concentrations have not been well characterized in CKD.
Cohort (n=3,939)
Plasma prorenin and renin concentrations decrease over time in patients with CKD, particularly in those with severe CKD at baseline.
Answers are grounded in this paper and cite their sources.
Declines in prorenin and renin over time may complicate RAAS biomarker interpretation in CKD; leaves open associations with outcomes in diverse groups.
INTRODUCTION: Prorenin, a precursor of renin, and renin play an important role in regulation of the renin-angiotensin system. More recently, receptor-bound prorenin has been shown to activate intracellular signaling pathways that mediate fibrosis, independent of angiotensin II. Prorenin and renin may thus be of physiologic significance in CKD, but their plasma concentrations have not been well characterized in CKD. METHODS: We evaluated distribution and longitudinal changes of prorenin and renin concentrations in the plasma samples collected at follow-up years 1, 2, 3, and 5 of the Chronic Renal Insufficiency Cohort (CRIC) study, an ongoing longitudinal observational study of 3,939 adults with CKD. Descriptive statistics and multivariable regression of log-transformed values were used to describe cross-sectional and longitudinal variation and associations with participant characteristics. RESULTS: A total of 3,361 CRIC participants had plasma available for analysis at year 1. The mean age (±standard deviation, SD) was 59 ± 11 years, and the mean estimated glomerular filtration rate (eGFR, ± SD) was 43 ± 17 mL/min per 1.73 m2. Median (interquartile range) values of plasma prorenin and renin at study entry were 4.4 (2.1, 8.8) ng/mL and 2.0 (0.8, 5.9) ng/dL, respectively. Prorenin and renin were positively correlated (Spearman correlation 0.51, p < 0.001) with each other. Women and non-Hispanic blacks had lower prorenin and renin values at year 1. Diabetes, lower eGFR, and use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, and diuretics were associated with higher levels. Prorenin and renin decreased by a mean of 2 and 5% per year, respectively. Non-Hispanic black race and eGFR <30 mL/min/1.73 m2 at year 1 predicted a steeper decrease in prorenin and renin over time. In addition, each increase in urinary sodium excretion by 2 SDs at year 1 increased prorenin and renin levels by 4 and 5% per year, respectively. DISCUSSION/CONCLUSIONS: The cross-sectional clinical factors associated with prorenin and renin values were similar. Overall, both plasma prorenin and renin concentrations decreased over the years, particularly in those with severe CKD at study entry.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2021) conducted a cohort in Chronic Kidney Disease (n=3,939). Chronic kidney disease was evaluated on Longitudinal changes in prorenin and renin concentrations. In adults with chronic kidney disease, plasma prorenin and renin concentrations decreased by a mean of 2% and 5% per year, respectively, with steeper declines in those with severe CKD.
Synapse has enriched 10 related papers. Consider them for comparative context: